Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Costiloe

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Heart Journal|December 1, 1975
Twenty-four hour automatic monitoring of blood pressure and heart rate at work and at homeR A Schneider, J P Costiloe
Archives of Environmental Health|January 1, 1972
Seasonal variation in cardiovascular functioningR A Schneider, J P Costiloe
The New England Journal of Medicine|March 25, 1971
Safety of lap-belt restraint for pregnant victims of automobile collisionsW M Crosby, J P Costiloe
Journal of Chronic Diseases|February 1, 1971
Arterial pressures recorded in hospital and during ordinary daily activities: contrasting data in subjects with and without ischemic heart diseaseR A Schneider, J P Costiloe, S Wolf
Journal of Clinical Pharmacology|August 1, 1977
Evaluation of butaclamol in chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
Psychopharmacology Communications|January 1, 1975
Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
The American Journal of Clinical Nutrition|March 1, 1978
Relationship of maternal amino acid profiles at 25 weeks of gestation to fetal growthP E McClain, J Metcoff, W M Crosby, et al.
Journal of Clinical Pharmacology|April 1, 1975
Loxapine in newly admitted chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
Diseases of the Nervous System|November 1, 1977
Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range designM L Clark, J P Costiloe, F Wood, et al.
Diseases of the Nervous System|December 1, 1972
Evaluation of loxapine succinate in chronic schizophreniaM L Clark, W K Huber, J Sullivan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Heart Journal|December 1, 1975
Twenty-four hour automatic monitoring of blood pressure and heart rate at work and at homeR A Schneider, J P Costiloe
Archives of Environmental Health|January 1, 1972
Seasonal variation in cardiovascular functioningR A Schneider, J P Costiloe
The New England Journal of Medicine|March 25, 1971
Safety of lap-belt restraint for pregnant victims of automobile collisionsW M Crosby, J P Costiloe
Journal of Chronic Diseases|February 1, 1971
Arterial pressures recorded in hospital and during ordinary daily activities: contrasting data in subjects with and without ischemic heart diseaseR A Schneider, J P Costiloe, S Wolf
Journal of Clinical Pharmacology|August 1, 1977
Evaluation of butaclamol in chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
Psychopharmacology Communications|January 1, 1975
Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
The American Journal of Clinical Nutrition|March 1, 1978
Relationship of maternal amino acid profiles at 25 weeks of gestation to fetal growthP E McClain, J Metcoff, W M Crosby, et al.
Journal of Clinical Pharmacology|April 1, 1975
Loxapine in newly admitted chronic schizophrenic patientsM L Clark, A Paredes, J P Costiloe, et al.
Diseases of the Nervous System|November 1, 1977
Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range designM L Clark, J P Costiloe, F Wood, et al.
Diseases of the Nervous System|December 1, 1972
Evaluation of loxapine succinate in chronic schizophreniaM L Clark, W K Huber, J Sullivan, et al.
Pageof 2